Lenzing Insiders Snap Up Rights at €1.55 as Berenberg Cuts Target to €17
Published on 10/11/2026 at 13:20 | Editorial boerse-global.de
Oberbank has picked up six Lenzing subscription rights at EUR 1.5500 apiece, a Friday filing showed, with the transaction executed a day earlier under the fibre maker's announced cash capital increase. The disclosure adds to a run of mandatory notifications that trace activity in the rights themselves — not the purchase of new Lenzing shares.
Rights, Allocations and Insider Moves
The Oberbank trade sits alongside a Thursday notice covering the allocation of subscription rights to the same institution. Lenzing supervisory and management figures feature too: board member Christian Skilich was allocated rights, and both allocations were booked at a price of EUR 0.00. Separately, Lenzing reported on Friday that chief executive Georg Kasperkovitz acquired subscription rights, a transaction also dated Thursday and likewise recorded at EUR 0 per unit.
The distinction matters for anyone reading the filings. Every one of these transactions concerns subscription rights tied to the capital increase, a different event from subscribing to and later receiving new shares. The rights Oberbank bought for cash are equally distinct from the zero-priced allocations.
The €300 Million Framework
All of this unfolds against a fully underwritten cash capital increase announced roughly a week ago. Lenzing is targeting proceeds of about EUR 300 million, with a subscription price of EUR 8.65 per share and a ratio of 10:9. Management says the money will support its corporate strategy and shore up the capital structure. The recent rights filings are therefore byproducts of that financing rather than standalone news on revenue, profit or operations.
Should investors sell immediately? Or is it worth buying Lenzing?
Analyst sentiment has moved in the opposite direction. According to media reports, Berenberg downgraded the stock from "Buy" to "Hold" about a week ago, cutting its price target to EUR 17.00 from EUR 29.50. The broker cited weaker pass-through of higher raw material costs into earnings, along with the announced capital increase.
What Shareholders Are Actually Deciding
For existing holders, the choice is whether to commit fresh capital to the strategic realignment. Underwriting the issue is one thing; whether a strengthened balance sheet ultimately delivers value for shareholders is another. The terms are fixed — EUR 8.65 per share, 10:9 — but the payoff depends on how Lenzing deploys the proceeds.
That is where the guarantee has limits. A fully underwritten emission secures the financing; it does not answer what return the funded initiatives might generate. Investors would do well to keep two layers apart: the provision of additional funds on one side, and the company's ability to convert them into a more durable business on the other. A successful raise is a precondition for the intended transformation, not proof of it.
The scale of the issuance sharpens the pressure. Lenzing plans to issue 34,756,362 new shares, a substantial expansion of the share count. The question is not merely whether the company gets the money, but whether the funded realignment can generate enough economic benefit to justify the larger share base. If that benefit falls short of expectations, the financing may be secured while the investment case remains unproven.
Participation appetite is uneven. According to Handelsblatt, Suzano does not intend to participate fully in the capital increase — an intention that does not equate to the financing failing, though it remains relevant how investors read the differing levels of commitment.
Lenzing at a turning point? This analysis reveals what investors need to know now.
Key Dates Ahead
Trading in the subscription rights is scheduled to run until 14 October. The subscription period is set to close on 20 October, the same day Lenzing plans an international private placement of any new shares not taken up. Settlement and delivery of the new shares, along with the start of their trading, are expected from 23 October, subject to registration of the capital increase in the commercial register.
Those deadlines frame the decision without settling it. They confirm neither completion of the capital increase nor its later success. For shareholders, the takeaway is a clean split: the upcoming subscription decision concerns capital deployment, while the longer-term verdict rests on what Lenzing makes of it.
Ad
Lenzing Stock: New Analysis - 11 October
Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
